Arc Universities

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

Read more

 

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

 

Tags:

Cranfield highly ranked for working with businesses
University provides Net Zero support to local businesses
Working towards net zero
New guide from Oxford Brookes’ Edible Streets empowers communities to grow their own food
Oxford Brookes helping communities transform their community gardens
Oxford’s calling! New platform is launched to support global businesses access innovation and investment opportunities in Oxfordshire
Showcasing Oxfordshire’s globally significant innovation ecosystem
Student Panel blog: Sustainability Intelligence (SI): A Journey, Not a Destination – Gurpreet Singh
Student panel blog
AUG Student Panel: Exploring University-Business partnerships for greater impact
New Report: Stronger Together – Why We Need an Expanded Role for Universities and University Groupings
Authored by AUG Director, Alistair Lomax
Adopting net zero technologies will save UK economy billions, finds Oxford University analysis
The UK could meet its 2030 net zero targets with £6-8bn of public sector investment a year.
REPLAY: Creating a Scientific Superpower – Unlocking the UK’s potential
Listen to the recordings or read the transcripts
ARU Professor asks for businesses to measure cost to planet
How can capital flow towards activities which protect ecosystems?